Bristol-Myers Squibb Company (BMY) vs Medtronic plc (MDT)
BMY leads on 14 of 17 compared metrics.
A side-by-side comparison of Bristol-Myers Squibb Company and Medtronic plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — BMY vs MDT
growth of $100 · last 30yBMY +171.1%MDT +462.8%MDT compounded faster
BMY MDT
BMY vs MDT: by the numbers
- •BMY is the larger company ($116.66B vs $102.97B market cap).
- •BMY trades at the lower earnings multiple (16.05 vs 21.50 P/E).
- •BMY converts more revenue to profit (15.01% vs 13.20% net margin).
- •MDT grew revenue faster over the past five years (5.18% vs 2.52% CAGR).
- •BMY pays the higher dividend yield (4.38% vs 3.54%).
Which is better, BMY or MDT?
Metric tally: BMY 14 · MDT 3It depends on what you're optimizing for:
ValueBMY(lower P/E)
GrowthMDT(faster 5Y revenue CAGR)
IncomeBMY(higher dividend yield)
QualityBMY(higher ROIC)
Valuation
| Metric | BMY | MDT |
|---|---|---|
| P/E ratio | 16.05● | 21.50 |
| Forward P/E | 9.31● | 12.56 |
| P/S ratio | 2.41● | 2.84 |
| P/B ratio | 5.82 | 2.11● |
| PEG ratio | 1.71● | 6.73 |
| EV / EBITDA | 11.03● | 13.03 |
| FCF yield | 10.20%● | 5.25% |
Profitability
| Metric | BMY | MDT |
|---|---|---|
| Gross margin | 68.75%● | 65.02% |
| Operating margin | 25.67%● | 17.78% |
| Net margin | 15.01%● | 13.20% |
| ROE | 36.25%● | 9.80% |
| ROIC | 13.90%● | 0.00% |
Dividends
| Metric | BMY | MDT |
|---|---|---|
| Dividend yield | 4.38%● | 3.54% |
| Payout ratio | 72.25% | 75.73% |
Growth (annualized)
| Metric | BMY | MDT |
|---|---|---|
| Revenue CAGR (5Y) | 2.52% | 5.18%● |
| EPS CAGR (5Y) | 9.38%● | 0.83% |
| FCF CAGR (5Y) | -2.50% | 3.07%● |
| Total return CAGR (5Y) | 0.74%● | -5.47% |
Frequently asked
- Which is better, BMY or MDT?
- It depends on your goal. value: BMY (lower P/E); growth: MDT (faster 5Y revenue CAGR); income: BMY (higher dividend yield); quality: BMY (higher ROIC). Across all compared metrics, BMY leads 14 to 3.
- Is BMY or MDT cheaper?
- On trailing earnings, BMY is cheaper: BMY trades at a 16.05 P/E and MDT at 21.50.
- Which has grown faster, BMY or MDT?
- Over the past five years, MDT grew revenue faster — BMY at a 2.52% CAGR versus MDT at 5.18%.
- Does BMY or MDT pay a bigger dividend?
- BMY yields 4.38% and MDT yields 3.54% based on trailing dividends and the latest price.
- Is BMY or MDT more profitable?
- BMY runs the higher net margin — BMY at 15.01% versus MDT at 13.20%.
- Which has been the better investment, BMY or MDT?
- Over the past 10-year, MDT delivered the higher annualized total return — BMY at 1.08% versus MDT at 1.97%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bristol-Myers Squibb P/E ratioMedtronic P/E ratioBristol-Myers Squibb dividend yieldMedtronic dividend yieldBristol-Myers Squibb ROEMedtronic ROEBristol-Myers Squibb operating marginMedtronic operating marginBristol-Myers Squibb revenue growthMedtronic revenue growthBristol-Myers Squibb free cash flowMedtronic free cash flow
Bristol-Myers Squibb & Medtronic appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.